Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Huntexil, pridopidine (formerly ACR16)
print preview
bookmark
share with colleague
General Information
Company
NeuroSearch A/S
Description
Dopamine stabilizer
Molecular Target
Dopamine receptor
Mechanism of Action
Dopamine stabilizer
Latest Stage of Development
Phase III
Indication
Huntington's disease (HD)
Partner
Teva Pharmaceutical Industries Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information